Edited by Gerald HartLamprey angiotensinogen (l-ANT) is a hormone carrier in the regulation of blood pressure, but it is also a heparin-dependent thrombin inhibitor in lamprey blood coagulation system. The detailed mechanisms on how angiotensin is carried by l-ANT and how heparin binds l-ANT and mediates thrombin inhibition are unclear. Here we have solved the crystal structure of cleaved l-ANT at 2.7 Å resolution and characterized its properties in heparin binding and protease inhibition. The structure reveals that l-ANT has a conserved serpin fold with a labile N-terminal angiotensin peptide and undergoes a typical stressed-to-relaxed conformational change when the reactive center loop is cleaved. Heparin binds l-ANT tightly with a dissociation constant of ϳ10 nM involving ϳ8 monosaccharides and ϳ6 ionic interactions. The heparin binding site is located in an extensive positively charged surface area around helix D involving residues Lys-148, Lys-151, Arg-155, and Arg-380. Although l-ANT by itself is a poor thrombin inhibitor with a second order rate constant of 500 M ؊1 s ؊1 , its interaction with thrombin is accelerated 90-fold by high molecular weight heparin following a bell-shaped dose-dependent curve. Short heparin chains of 6 -20 monosaccharide units are insufficient to promote thrombin inhibition. Furthermore, an l-ANT mutant with the P1 Ile mutated to Arg inhibits thrombin nearly 1500-fold faster than the wild type, which is further accelerated by high molecular weight heparin. Taken together, these results suggest that heparin binds l-ANT at a conserved heparin binding site around helix D and promotes the interaction between l-ANT and thrombin through a template mechanism conserved in vertebrates.Angiotensinogen genes exist throughout all vertebrates and have evolved over 500 million years from early cyclostome (lamprey) to human (1-3). Angiotensinogen functions as the carrier of active angiotensin hormones of the renin-angiotensin system that regulates body fluid homeostasis, blood pressure, and blood vessel formation (4, 5).Early studies have shown that angiotensinogen with the angiotensin peptide located at its N terminus belongs to the serine protease inhibitor (serpin) superfamily (6, 7). All serpins are known to share similar tertiary structures with three -sheets, 8 -9 ␣-helices, and an exposed reactive center loop (RCL) 4 that serves as a bait for proteolytic attack (8, 9). Once the target protease recognizes and cleaves RCL, the serpin undergoes a typical serpin stressed-to-relaxed (S-to-R) transition with the insertion of the cleaved RCL into the central -sheet as a middle strand, which leads to translocation and inactivation of the covalently linked protease (10, 11).Classically, angiotensinogen is regarded as a passive hormone carrier and a non-inhibitory serpin that lacks serpin S-to-R conformational rearrangements upon RCL cleavage (12, 13); however, recent studies have found that angiotensinogen derived from lamprey, a representative of an early lineage of vertebrate, to be an inhi...